Interventional Coronary Physiology: A 30-Year Overnight Success Story
Dr. Morton Kern and Dr. C. Michael Gibson Discuss
State of the Art in Transseptal Therapies
Dr. Zoltan Turi, Dr. George Hanzel and Dr. C. Michael Gibson Discuss
Top Sessions for Cardiovascular Professionals at SCAI 2017
Jeff Davis, Bernadette Speiser, Rena Silver and Dr. C. Michael Gibson Discuss
Opportunities and Challenges for the Cardiovascular Interventionalists
Dr. Christopher White and Dr. C. Michael Gibson Discuss
Intersection of Coronary Artery Disease and TAVR
Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss
Pediatric Interventional Cardiology: Alice in Wonderland or Fred Astaire and Ginger Rogers?
Dr. Lee Benson and Dr. C. Michael Gibson Discuss
SCAI Global Partnerships
Dr. David Zhao, Dr. Luis Guzman and Dr. C. Michael Gibson Discuss
The Presidential Address and Goals for SCAI 2018
Dr. Kirk Garratt and Dr. C. Michael Gibson Discuss
Effect of Bivalirudin Versus UFH in Patients with AFib in TAVR
Dr. Usman Baber and Dr. C. Michael Gibson Discuss
Importance of Patient Education
Dr. Lyndon Box, Rena Silver and Dr. C. Michael Gibson Discuss
T4V Launch and Transradial for CHIP/CTO
Dr. Sunil Rao, Dr. Adhir Shroff and Dr. C. Michael Gibson Discuss
Intersection of CAD and TAVR
Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss
Fall Fellows: What to Expect and Why Attend?
Dr. Douglas Drachman, Dr. John Messenger and Dr. C. Michael Gibson Discuss
Outcomes of Radial vs. Femoral-Access Robotic PCI
Dr. Ehtisham Mahmud and Dr. C. Michael Gibson Discuss